Is EyePoint Pharmaceuticals, Inc. (EYPT) a Buy, Sell, or Hold?
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$13.73 USD
-$0.55 (-3.85%)
- Volume
- 1.06M
- Average Volume
- 1.15M
- Market Capitalization
- $1.15B
- P/E Ratio
- -3.92
- Dividend Yield
- 0.00%
- Price Target
- $37.50
- Year High
- $19.11
- Year Low
- $9.40
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.66
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-63.4% DOWNSIDE
$37.50 Price Target
UPSIDE/DOWNSIDE HIGH
-64.8% DOWNSIDE
$39.00 Price Target High
UPSIDE/DOWNSIDE LOW
-61.9% DOWNSIDE
$36.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Lisa Walter | $39 | $13.22 | 2026-02-05 08:54 AM | 195.0% |
| Mizuho Securities | Graig Suvannavejh | $33 | $12.25 | 2025-10-29 08:50 AM | 169.4% |
| Mizuho Securities | Graig Suvannavejh | $28 | $11.63 | 2025-10-20 06:55 AM | 140.8% |
| H.C. Wainwright | Yi Chen | $22 | $11.585 | 2024-11-11 07:23 AM | 89.9% |
| H.C. Wainwright | Yi Chen | $30 | $12.17 | 2024-05-13 03:17 AM | 146.5% |
| Mizuho Securities | Graig Suvannavejh | $30 | $11.2 | 2024-05-07 02:34 AM | 167.9% |